FLT3 and acute myeloid leukemia: Since DNMT3A-R882 mutations were increased in the short-lived group, we analyzed if mutations of FLT3 or/and NPM1 are found more frequently in AML patients with DNMT3A-R882 mutations compared to patients with other DNMT3A mutations.